Annual CAPEX
$10.58 M
+$334.00 K+3.26%
31 December 2023
Summary:
Core Laboratories NV annual capital expenditures is currently $10.58 million, with the most recent change of +$334.00 thousand (+3.26%) on 31 December 2023. During the last 3 years, it has fallen by -$1.80 million (-14.53%). CLB annual CAPEX is now -88.72% below its all-time high of $93.80 million, reached on 31 December 1997.CLB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$2.73 M
-$140.00 K-4.88%
30 September 2024
Summary:
Core Laboratories NV quarterly capital expenditures is currently $2.73 million, with the most recent change of -$140.00 thousand (-4.88%) on 30 September 2024. Over the past year, it has dropped by -$729.00 thousand (-21.10%). CLB quarterly CAPEX is now -96.73% below its all-time high of $83.40 million, reached on 31 December 1997.CLB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$11.22 M
-$729.00 K-6.10%
30 September 2024
Summary:
Core Laboratories NV TTM capital expenditures is currently $11.22 million, with the most recent change of -$729.00 thousand (-6.10%) on 30 September 2024. Over the past year, it has increased by +$1.20 million (+11.98%). CLB TTM CAPEX is now -88.92% below its all-time high of $101.30 million, reached on 30 September 1998.CLB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | -21.1% | +12.0% |
| 3 y3 years | -14.5% | -15.7% | -9.9% |
| 5 y5 years | -53.9% | -49.5% | -52.3% |
CLB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -23.7% | +3.3% | -43.4% | +34.8% | -19.0% | +21.3% |
| 5 y | 5 years | -53.9% | +3.3% | -49.5% | +34.8% | -52.3% | +21.3% |
| alltime | all time | -88.7% | +360.0% | -96.7% | +240.8% | -88.9% | +1303.1% |
Core Laboratories NV CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.73 M(-4.9%) | $11.22 M(-6.1%) |
| June 2024 | - | $2.87 M(-6.2%) | $11.95 M(+4.6%) |
| Mar 2024 | - | $3.06 M(+18.5%) | $11.43 M(+8.0%) |
| Dec 2023 | $10.58 M(+3.3%) | $2.58 M(-25.4%) | $10.58 M(+5.5%) |
| Sept 2023 | - | $3.46 M(+47.8%) | $10.02 M(+8.3%) |
| June 2023 | - | $2.34 M(+5.9%) | $9.26 M(-8.7%) |
| Mar 2023 | - | $2.21 M(+9.1%) | $10.14 M(-1.0%) |
| Dec 2022 | $10.24 M(-26.1%) | $2.02 M(-24.7%) | $10.24 M(-21.4%) |
| Sept 2022 | - | $2.69 M(-16.7%) | $13.04 M(-4.0%) |
| June 2022 | - | $3.23 M(+39.6%) | $13.59 M(+2.0%) |
| Mar 2022 | - | $2.31 M(-52.1%) | $13.32 M(-3.9%) |
| Dec 2021 | $13.86 M(+11.9%) | $4.82 M(+49.0%) | $13.86 M(+11.2%) |
| Sept 2021 | - | $3.23 M(+9.5%) | $12.46 M(+8.3%) |
| June 2021 | - | $2.95 M(+3.6%) | $11.50 M(-2.6%) |
| Mar 2021 | - | $2.85 M(-16.7%) | $11.81 M(-4.6%) |
| Dec 2020 | $12.38 M(-44.9%) | $3.42 M(+50.3%) | $12.38 M(-10.2%) |
| Sept 2020 | - | $2.28 M(-30.2%) | $13.78 M(-18.5%) |
| June 2020 | - | $3.26 M(-4.6%) | $16.90 M(-18.3%) |
| Mar 2020 | - | $3.42 M(-29.1%) | $20.68 M(-7.9%) |
| Dec 2019 | $22.45 M(-2.1%) | $4.82 M(-10.7%) | $22.45 M(-4.6%) |
| Sept 2019 | - | $5.40 M(-23.4%) | $23.52 M(+5.2%) |
| June 2019 | - | $7.05 M(+36.0%) | $22.37 M(-5.2%) |
| Mar 2019 | - | $5.18 M(-12.1%) | $23.60 M(+2.9%) |
| Dec 2018 | $22.93 M(+19.7%) | $5.90 M(+39.1%) | $22.93 M(+6.0%) |
| Sept 2018 | - | $4.24 M(-48.8%) | $21.64 M(-3.3%) |
| June 2018 | - | $8.28 M(+83.3%) | $22.38 M(+30.8%) |
| Mar 2018 | - | $4.51 M(-2.0%) | $17.12 M(-10.6%) |
| Dec 2017 | $19.15 M(+63.7%) | $4.61 M(-7.5%) | $19.15 M(+4.6%) |
| Sept 2017 | - | $4.98 M(+65.3%) | $18.30 M(+15.4%) |
| June 2017 | - | $3.01 M(-54.0%) | $15.87 M(+3.3%) |
| Mar 2017 | - | $6.55 M(+74.3%) | $15.36 M(+31.2%) |
| Dec 2016 | $11.70 M(-51.8%) | $3.76 M(+47.8%) | $11.70 M(-5.8%) |
| Sept 2016 | - | $2.54 M(+1.5%) | $12.42 M(-26.2%) |
| June 2016 | - | $2.51 M(-13.4%) | $16.84 M(-16.2%) |
| Mar 2016 | - | $2.89 M(-35.4%) | $20.10 M(-17.2%) |
| Dec 2015 | $24.26 M(-35.2%) | $4.48 M(-35.6%) | $24.26 M(-15.9%) |
| Sept 2015 | - | $6.96 M(+20.6%) | $28.84 M(-4.4%) |
| June 2015 | - | $5.77 M(-18.3%) | $30.17 M(-18.1%) |
| Mar 2015 | - | $7.05 M(-22.2%) | $36.83 M(-1.6%) |
| Dec 2014 | $37.44 M(-3.9%) | $9.06 M(+9.4%) | $37.44 M(+0.5%) |
| Sept 2014 | - | $8.29 M(-33.3%) | $37.25 M(-4.2%) |
| June 2014 | - | $12.42 M(+62.0%) | $38.87 M(+4.2%) |
| Mar 2014 | - | $7.67 M(-13.6%) | $37.32 M(-4.2%) |
| Dec 2013 | $38.95 M(+18.7%) | $8.88 M(-10.4%) | $38.95 M(+3.5%) |
| Sept 2013 | - | $9.91 M(-8.9%) | $37.62 M(+0.6%) |
| June 2013 | - | $10.87 M(+17.1%) | $37.38 M(+7.9%) |
| Mar 2013 | - | $9.29 M(+23.1%) | $34.65 M(+5.6%) |
| Dec 2012 | $32.80 M(+8.8%) | $7.55 M(-21.9%) | $32.80 M(-11.4%) |
| Sept 2012 | - | $9.67 M(+18.9%) | $37.02 M(+10.1%) |
| June 2012 | - | $8.13 M(+9.3%) | $33.61 M(+1.3%) |
| Mar 2012 | - | $7.44 M(-36.7%) | $33.18 M(+10.1%) |
| Dec 2011 | $30.15 M(+8.4%) | $11.77 M(+87.9%) | $30.15 M(+14.4%) |
| Sept 2011 | - | $6.26 M(-18.7%) | $26.34 M(-2.7%) |
| June 2011 | - | $7.71 M(+74.8%) | $27.08 M(+4.3%) |
| Mar 2011 | - | $4.41 M(-44.6%) | $25.97 M(-6.6%) |
| Dec 2010 | $27.80 M | $7.96 M(+13.7%) | $27.80 M(+2.3%) |
| Sept 2010 | - | $7.00 M(+6.1%) | $27.18 M(+9.2%) |
| June 2010 | - | $6.60 M(+5.8%) | $24.90 M(+18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $6.24 M(-15.0%) | $21.02 M(+19.9%) |
| Dec 2009 | $17.53 M(-44.0%) | $7.34 M(+55.8%) | $17.53 M(-10.7%) |
| Sept 2009 | - | $4.71 M(+73.3%) | $19.63 M(-14.5%) |
| June 2009 | - | $2.72 M(-1.1%) | $22.97 M(-19.0%) |
| Mar 2009 | - | $2.75 M(-70.9%) | $28.35 M(-9.4%) |
| Dec 2008 | $31.30 M(+29.7%) | $9.45 M(+17.4%) | $31.30 M(+2.8%) |
| Sept 2008 | - | $8.05 M(-0.7%) | $30.46 M(+4.2%) |
| June 2008 | - | $8.11 M(+42.1%) | $29.25 M(+10.9%) |
| Mar 2008 | - | $5.70 M(-33.7%) | $26.38 M(+9.2%) |
| Dec 2007 | $24.14 M(-2.2%) | $8.61 M(+26.0%) | $24.14 M(+1.6%) |
| Sept 2007 | - | $6.83 M(+30.5%) | $23.77 M(+1.2%) |
| June 2007 | - | $5.24 M(+50.8%) | $23.50 M(-1.6%) |
| Mar 2007 | - | $3.47 M(-57.8%) | $23.87 M(-3.3%) |
| Dec 2006 | $24.68 M(+29.3%) | $8.23 M(+25.5%) | $24.68 M(+6.6%) |
| Sept 2006 | - | $6.56 M(+17.0%) | $23.15 M(+13.6%) |
| June 2006 | - | $5.61 M(+30.8%) | $20.39 M(+1.4%) |
| Mar 2006 | - | $4.29 M(-36.1%) | $20.10 M(+5.3%) |
| Dec 2005 | $19.09 M(+75.4%) | $6.70 M(+76.6%) | $19.09 M(+18.8%) |
| Sept 2005 | - | $3.79 M(-28.7%) | $16.07 M(+1.6%) |
| June 2005 | - | $5.32 M(+62.0%) | $15.81 M(+24.1%) |
| Mar 2005 | - | $3.28 M(-10.6%) | $12.74 M(+17.0%) |
| Dec 2004 | $10.89 M(-40.8%) | $3.67 M(+3.8%) | $10.89 M(-8.9%) |
| Sept 2004 | - | $3.54 M(+57.3%) | $11.96 M(+5.6%) |
| June 2004 | - | $2.25 M(+57.2%) | $11.32 M(-24.8%) |
| Mar 2004 | - | $1.43 M(-69.8%) | $15.05 M(-18.1%) |
| Dec 2003 | $18.38 M(+10.3%) | $4.74 M(+63.2%) | $18.38 M(+12.2%) |
| Sept 2003 | - | $2.90 M(-51.4%) | $16.37 M(+0.8%) |
| June 2003 | - | $5.98 M(+25.7%) | $16.24 M(-6.7%) |
| Mar 2003 | - | $4.75 M(+73.7%) | $17.40 M(+4.4%) |
| Dec 2002 | $16.66 M(-42.6%) | $2.74 M(-1.1%) | $16.66 M(-24.8%) |
| Sept 2002 | - | $2.77 M(-61.3%) | $22.15 M(-16.2%) |
| June 2002 | - | $7.14 M(+78.0%) | $26.42 M(-5.3%) |
| Mar 2002 | - | $4.01 M(-51.2%) | $27.90 M(-3.9%) |
| Dec 2001 | $29.05 M(-12.9%) | $8.23 M(+16.9%) | $29.05 M(+0.8%) |
| Sept 2001 | - | $7.04 M(-18.4%) | $28.81 M(+1.0%) |
| June 2001 | - | $8.62 M(+67.1%) | $28.52 M(-8.0%) |
| Mar 2001 | - | $5.16 M(-35.4%) | $30.98 M(-7.1%) |
| Dec 2000 | $33.35 M(+65.3%) | $7.99 M(+18.5%) | $33.35 M(+15.3%) |
| Sept 2000 | - | $6.75 M(-39.2%) | $28.93 M(+0.1%) |
| June 2000 | - | $11.09 M(+47.2%) | $28.89 M(+31.1%) |
| Mar 2000 | - | $7.53 M(+110.9%) | $22.04 M(+9.3%) |
| Dec 1999 | $20.17 M(-36.5%) | $3.57 M(-46.7%) | $20.17 M(-33.8%) |
| Sept 1999 | - | $6.70 M(+58.2%) | $30.48 M(-10.0%) |
| June 1999 | - | $4.24 M(-25.1%) | $33.88 M(+0.7%) |
| Mar 1999 | - | $5.66 M(-59.2%) | $33.64 M(+5.9%) |
| Dec 1998 | $31.78 M(-66.1%) | $13.88 M(+37.5%) | $31.78 M(-68.6%) |
| Sept 1998 | - | $10.10 M(+152.5%) | $101.30 M(+6.0%) |
| June 1998 | - | $4.00 M(+5.3%) | $95.60 M(+0.7%) |
| Mar 1998 | - | $3.80 M(-95.4%) | $94.90 M(+1.2%) |
| Dec 1997 | $93.80 M(+715.7%) | $83.40 M(+1795.5%) | $93.80 M(+442.2%) |
| Sept 1997 | - | $4.40 M(+33.3%) | $17.30 M(+11.6%) |
| June 1997 | - | $3.30 M(+22.2%) | $15.50 M(+15.7%) |
| Mar 1997 | - | $2.70 M(-60.9%) | $13.40 M(+16.5%) |
| Dec 1996 | $11.50 M(+400.0%) | $6.90 M(+165.4%) | $11.50 M(+150.0%) |
| Sept 1996 | - | $2.60 M(+116.7%) | $4.60 M(+130.0%) |
| June 1996 | - | $1.20 M(+50.0%) | $2.00 M(+150.0%) |
| Mar 1996 | - | $800.00 K | $800.00 K |
| Dec 1995 | $2.30 M | - | - |
FAQ
- What is Core Laboratories NV annual capital expenditures?
- What is the all time high annual CAPEX for Core Laboratories NV?
- What is Core Laboratories NV annual CAPEX year-on-year change?
- What is Core Laboratories NV quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Core Laboratories NV?
- What is Core Laboratories NV quarterly CAPEX year-on-year change?
- What is Core Laboratories NV TTM capital expenditures?
- What is the all time high TTM CAPEX for Core Laboratories NV?
- What is Core Laboratories NV TTM CAPEX year-on-year change?
What is Core Laboratories NV annual capital expenditures?
The current annual CAPEX of CLB is $10.58 M
What is the all time high annual CAPEX for Core Laboratories NV?
Core Laboratories NV all-time high annual capital expenditures is $93.80 M
What is Core Laboratories NV annual CAPEX year-on-year change?
Over the past year, CLB annual capital expenditures has changed by +$334.00 K (+3.26%)
What is Core Laboratories NV quarterly capital expenditures?
The current quarterly CAPEX of CLB is $2.73 M
What is the all time high quarterly CAPEX for Core Laboratories NV?
Core Laboratories NV all-time high quarterly capital expenditures is $83.40 M
What is Core Laboratories NV quarterly CAPEX year-on-year change?
Over the past year, CLB quarterly capital expenditures has changed by -$729.00 K (-21.10%)
What is Core Laboratories NV TTM capital expenditures?
The current TTM CAPEX of CLB is $11.22 M
What is the all time high TTM CAPEX for Core Laboratories NV?
Core Laboratories NV all-time high TTM capital expenditures is $101.30 M
What is Core Laboratories NV TTM CAPEX year-on-year change?
Over the past year, CLB TTM capital expenditures has changed by +$1.20 M (+11.98%)